Career Enhancement Program

项目总结(职业提升计划) MD安德森癌症中心前列腺癌职业提升计划(CEP)的目标 孢子(前列腺癌孢子)是培养一支致力于翻译研究的研究队伍 人类前列腺癌。该片由加里·E·加里克博士执导，克里斯托弗·J·洛戈蒂斯博士联合执导。 该计划将：1)招募创新的入门级科学家到前列腺癌孢子，以提高 孢子的整体翻译研究能力，为我们的项目带来新的技术和人才；2) 帮助这些人培养成为高效调查人员所需的智力和技术技能 转译前列腺癌研究；3)教这些人癌症生物学的基本原理，而不是 通常包括在临床培训或博士学位课程中；以及4)指导入门级科学家 翻译前列腺癌研究领域竞争性拨款提案的发展。这个 MD Anderson独特的教育环境将确保实现这些目标。至少两个职业 在积极资助期内，我们会每年从合资格的候选人中选出优秀奖得主。 MD Anderson内外根据定义的标准响应孢子请求的人员。特价 将把重点放在招募合格的妇女和少数群体成员上 有可能。作为对之前批评的回应，洛格西蒂斯博士将积极参与招聘合格的 医生/科学家增加获得CEP的MD数量。导师制培训将包括以下原则 癌症生物学、科学方法、统计分析、生物医学交流和策略 在转化型前列腺癌研究中取得成功所必需的。加州大学的几门课程 休斯顿的德克萨斯生物医学研究生院包含这些学科 CEP收件人。CEP获奖者将每年接受评估，遴选过程和培训将 在适当的时候修改。此外，获奖者对他们的导师的“向上”评价也会发生 每年，并根据CEP接受者的意见对计划进行必要的修改(见 附录《CEP试点项目评审表》和《CEP评价表》(评价标准)。 九个职业发展奖(现在的职业发展奖)由前列腺癌资助 癌症孢子。获得CDP奖的调查人员撰写了53份出版物。共25份外部审查报告 赠款申请得到了资助。值得注意的是，CDP奖获得者林慧坤博士将提交一份 孢子研究计划(DRP)项目，反映CEP和CEP之间的协同关系 DRP机制。Ana Aparicio博士，泌尿生殖内科肿瘤学家，是CEP奖获得者。

PROJECT SUMMARY (Career Enhancement Program) The goal of the Career Enhancement Program (CEP) of the MD Anderson Cancer Center Prostate Cancer SPORE (Prostate Cancer SPORE) is to develop a cadre of investigators dedicated to translational studies of human prostate cancer. It is directed by Dr. Gary E. Gallick and co-directed by Dr. Christopher J. Logothetis. The program will: 1) recruit innovative entry-level scientists to the Prostate Cancer SPORE to enhance the overall translational research capability of the SPORE and bring new techniques and talent to our program; 2) help these individuals develop the intellectual and technical skills required to be productive investigators in translational prostate cancer research; 3) teach these individuals basic principles of cancer biology not commonly included in clinical training or doctoral degree programs; and 4) guide the entry-level scientists in the development of competitive grant proposals in the area of translational prostate cancer research. The unique educational environment at MD Anderson will ensure that these goals will be met. At least two Career Enhancement awardees will be selected annually during the active funding period from qualified candidates within and outside MD Anderson who respond to a SPORE solicitation based on the defined criteria. Special emphasis will be placed on recruiting qualified women and members of minority populations whenever possible. In response to the previous critique, Dr. Logothetis will be actively involved in recruiting qualified physician/scientists to increase the number of MDs obtaining CEPs. Mentorship training will include principles of cancer biology, scientific methods, statistical analysis, biomedical communications, and strategies necessary to become successful in translational prostate cancer research. Several courses in The University of Texas Graduate School of Biomedical Sciences at Houston that encompass these disciplines are available to CEP recipients. The CEP recipients will be evaluated annually, and the selection process and training will be modified when appropriate. In addition, “upward” evaluation by recipients to their mentors will also occur annually, with modifications to the program made, as necessary, in response to input of CEP recipients (see Appendix “CEP Pilot Project Review Form” and “CEP Evaluation Form” for evaluation criteria). Nine Career Development awards (now Career Enhancement awards) have been funded by the Prostate Cancer SPORE. Investigators receiving CDP awards wrote 53 publications. A total of 25 externally reviewed grant applications were funded. Of note, Dr. Hui-Kuan Lin, a CDP awardee, will submit a Developmental Research Program (DRP) project to the SPORE, reflecting the synergistic relationship between the CEP and DRP mechanisms. Dr. Ana Aparicio, genitourinary medical oncologist, is a CEP awardee.